Annual Total Liabilities
$3.05 B
-$405.54 M-11.73%
31 December 2023
Summary:
BioNTech SE annual total liabilities is currently $3.05 billion, with the most recent change of -$405.54 million (-11.73%) on 31 December 2023. During the last 3 years, it has risen by +$1.89 billion (+162.02%). BNTX annual total liabilities is now -31.55% below its all-time high of $4.46 billion, reached on 31 December 2021.BNTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$3.67 B
+$277.71 M+8.18%
01 September 2024
Summary:
BioNTech SE quarterly total liabilities is currently $3.67 billion, with the most recent change of +$277.71 million (+8.18%) on 01 September 2024. Over the past year, it has increased by +$1.19 billion (+48.18%). BNTX quarterly total liabilities is now -42.68% below its all-time high of $6.40 billion, reached on 30 September 2021.BNTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.7% | +48.2% |
3 y3 years | +162.0% | -42.7% |
5 y5 years | +591.1% | +942.0% |
BNTX Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -31.6% | +162.0% | -42.7% | +85.6% |
5 y | 5 years | -31.6% | +795.6% | -42.7% | +1071.6% |
alltime | all time | -31.6% | +795.6% | -42.7% | +1071.6% |
BioNTech SE Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $3.67 B(+8.2%) |
June 2024 | - | $3.39 B(+37.3%) |
Mar 2024 | - | $2.47 B(-19.0%) |
Dec 2023 | $3.05 B(-11.7%) | $3.05 B(+23.2%) |
Sept 2023 | - | $2.48 B(-1.7%) |
June 2023 | - | $2.52 B(+27.4%) |
Mar 2023 | - | $1.98 B(-42.8%) |
Dec 2022 | $3.46 B(-22.5%) | $3.46 B(-18.1%) |
Sept 2022 | - | $4.22 B(-6.6%) |
June 2022 | - | $4.52 B(-7.8%) |
Mar 2022 | - | $4.90 B(+9.9%) |
Dec 2021 | $4.46 B | $4.46 B(-30.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $6.40 B(+46.8%) |
June 2021 | - | $4.36 B(+120.8%) |
Mar 2021 | - | $1.98 B(+69.6%) |
Dec 2020 | $1.16 B(+241.8%) | $1.16 B(+90.2%) |
Sept 2020 | - | $612.35 M(+46.6%) |
June 2020 | - | $417.83 M(+33.4%) |
Mar 2020 | - | $313.32 M(-8.0%) |
Dec 2019 | $340.71 M(-22.8%) | $340.71 M(-3.3%) |
Sept 2019 | - | $352.30 M(-8.3%) |
June 2019 | - | $384.17 M(-13.0%) |
Dec 2018 | $441.53 M(-13.0%) | $441.53 M |
Dec 2017 | $507.38 M(+34.0%) | - |
Dec 2016 | $378.57 M | - |
FAQ
- What is BioNTech SE annual total liabilities?
- What is the all time high annual total liabilities for BioNTech SE?
- What is BioNTech SE annual total liabilities year-on-year change?
- What is BioNTech SE quarterly total liabilities?
- What is the all time high quarterly total liabilities for BioNTech SE?
- What is BioNTech SE quarterly total liabilities year-on-year change?
What is BioNTech SE annual total liabilities?
The current annual total liabilities of BNTX is $3.05 B
What is the all time high annual total liabilities for BioNTech SE?
BioNTech SE all-time high annual total liabilities is $4.46 B
What is BioNTech SE annual total liabilities year-on-year change?
Over the past year, BNTX annual total liabilities has changed by -$405.54 M (-11.73%)
What is BioNTech SE quarterly total liabilities?
The current quarterly total liabilities of BNTX is $3.67 B
What is the all time high quarterly total liabilities for BioNTech SE?
BioNTech SE all-time high quarterly total liabilities is $6.40 B
What is BioNTech SE quarterly total liabilities year-on-year change?
Over the past year, BNTX quarterly total liabilities has changed by +$1.19 B (+48.18%)